We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Biofusion Launches Genophrenix Second Spin-out Company

News   Feb 23, 2006

 
Biofusion Launches Genophrenix Second Spin-out Company
 
 
 

RELATED ARTICLES

Promising New Drugs for an Old Pathogen

News

Tuberculosis (TB), an ancient and notoriously difficult disease to treat, has killed millions through the course of human history; and the antibiotics that have been used to fight the disease in recent history are becoming less and less effective. In the face of this reality, researcher Prof. Dennis Wright has improved upon a new way to thwart the tricky pathogen, mycobacterium tuberculosis.

READ MORE

“BridgIT” Identifies Candidate Genes and Catalyzing Proteins for Orphan and Novel Enzyme Reactions

News

Chemical engineers at EPFL have developed an online tool that can accurately assign genes and proteins to unknown “orphan” reactions, which are a major headache for biotechnology, drug development, and even medicine.

READ MORE

Differences Between Two Cancer-promoting Enzymes Discovered

News

Researchers have solved the structures of the cancer-promoting enzymes USP25 and USP28, and identified significant differences in their activities. This knowledge provides the molecular basis for the development of new and highly specific anti-cancer drugs, with a low risk of side-effects.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE